Wayne V. Moore, MD, PhD
| Title | Physician |
|---|
| Institution | Children's Mercy Kansas City |
|---|
| Department | Endocrinology |
|---|
| Address | 3101 Broadway Blvd Kansas City MO 64111
|
|---|
| vCard | Download vCard |
|---|
|
|
|
| Title | Professor |
|---|
| Institution | University of Missouri-Kansas City |
|---|
| Department | Pediatrics |
|---|
|
|---|
| Title | Clinical Professor |
|---|
| Institution | University of Kansas |
|---|
| Department | Pediatrics |
|---|
|
|---|
|
Biography | University of Minnesota School of Medicine, Minneapolis, MN | MD/PhD | 1970 | | | University of Minnesota Hospitals, Minneapolis, MN | Residency | 1972 | Pediatrics | | University of Minnesota Hospitals, Minneapolis, MN | Fellowship | 1970 | Pediatric Endocrinology |
Bibliography
-
Libman I, Bingley PJ, Becker D, Buckner JH, DiMeglio LA, Gitelman SE, Greenbaum C, Haller MJ, Ismail HM, Krischer J, Moore WV, Moran A, Muir AB, Raman V, Steck AK, Toledo FGS, Wentworth J, Wherrett D, White P, You L, Herold KC. Hydroxychloroquine in Stage 1 Type 1 Diabetes. Diabetes Care. 2023 11 01; 46(11):2035-2043. PMID: 37708415.
-
Russell WE, Bundy BN, Anderson MS, Cooney LA, Gitelman SE, Goland RS, Gottlieb PA, Greenbaum CJ, Haller MJ, Krischer JP, Libman IM, Linsley PS, Long SA, Lord SM, Moore DJ, Moore WV, Moran AM, Muir AB, Raskin P, Skyler JS, Wentworth JM, Wherrett DK, Wilson DM, Ziegler AG, Herold KC. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care. 2023 05 01; 46(5):1005-1013. PMID: 36920087.
-
He L, Lawrence V, Moore WV, Yan Y. Thyrotoxic periodic paralysis in an adolescent male: A case report and literature review. Clin Case Rep. 2021 Jan; 9(1):465-469. PMID: 33489198.
-
Child CJ, Quigley CA, Cutler GB, Moore WV, Wintergerst KA, Ross JL, Rosenfeld RG, Blum WF. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study. Horm Res Paediatr. 2019; 91(4):241-251. PMID: 31185471.
-
Li X, Kover KL, Heruth DP, Watkins DJ, Guo Y, Moore WV, He LG, Zang M, Clements MA, Yan Y. Thioredoxin-interacting protein promotes high-glucose-induced macrovascular endothelial dysfunction. Biochem Biophys Res Commun. 2017 11 04; 493(1):291-297. PMID: 28890350.
-
Gitelman SE, Gottlieb PA, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Harris KM, Kanaparthi S, Phippard D, Ding L, Bluestone JA, Ehlers MR. Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2?year results of a randomised trial. Diabetologia. 2016 06; 59(6):1153-61. PMID: 27053235.
-
Moore WV, Nguyen HJ, Kletter GB, Miller BS, Rogers D, Ng D, Moore JA, Humphriss E, Cleland JL, Bright GM. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency. J Clin Endocrinol Metab. 2016 Mar; 101(3):1091-7. PMID: 26672637.
-
Rigby MR, Harris KM, Pinckney A, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Keyes-Elstein L, Long SA, Kanaparthi S, Lim N, Phippard D, Soppe CL, Fitzgibbon ML, McNamara J, Nepom GT, Ehlers MR. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest. 2015 Aug 03; 125(8):3285-96. PMID: 26193635.
-
Li X, Kover KL, Heruth DP, Watkins DJ, Moore WV, Jackson K, Zang M, Clements MA, Yan Y. New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells. Mol Endocrinol. 2015 Aug; 29(8):1184-94. PMID: 26147751.
-
Kover K, Yan Y, Tong PY, Watkins D, Li X, Tasch J, Hager M, Clements M, Moore WV. Osteocalcin protects pancreatic beta cell function and survival under high glucose conditions. Biochem Biophys Res Commun. 2015 Jun 19; 462(1):21-6. PMID: 25930995.
-
Rigby MR, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Patel CM, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Moran A, Russell WE, Pinckney A, Keyes-Elstein L, Howell M, Aggarwal S, Lim N, Phippard D, Nepom GT, McNamara J, Ehlers MR. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diabetes Endocrinol. 2013 Dec; 1(4):284-94. PMID: 24622414.
-
Kover K, Tong PY, Watkins D, Clements M, Stehno-Bittel L, Novikova L, Bittel D, Kibiryeva N, Stuhlsatz J, Yan Y, Ye SQ, Moore WV. Expression and regulation of nampt in human islets. PLoS One. 2013; 8(3):e58767. PMID: 23536823.
-
Butler MG, Smith BK, Lee J, Gibson C, Schmoll C, Moore WV, Donnelly JE. Effects of growth hormone treatment in adults with Prader-Willi syndrome. Growth Horm IGF Res. 2013 Jun; 23(3):81-7. PMID: 23433655.
-
Kover K, Tong PY, Pacicca D, Clements M, Bodker AM, Eidson C, Sheldon M, Southard A, Zaidi A, Moore WV. Bone marrow cavity: a supportive environment for islet engraftment. Islets. 2011 May-Jun; 3(3):93-101. PMID: 21512317.
-
Moore WV, Dana K, Frane J, Lippe B. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study. Pediatr Endocrinol Rev. 2008 Sep; 6(1):5-8. PMID: 18806719.
-
Ugrasbul F, Moore WV, Tong PY, Kover KL. Prevention of diabetes: effect of mycophenolate mofetil and anti-CD25 on onset of diabetes in the DRBB rat. Pediatr Diabetes. 2008 Dec; 9(6):596-601. PMID: 18503494.
-
Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008 May; 3(3):658-64. PMID: 18256372.
-
Luetjen T, Moore WV. Bone density after completion of growth hormone treatment for growth failure. J Pediatr Endocrinol Metab. 2005 Nov; 18(11):1053-61. PMID: 16459451.
-
Karmazin A, Moore WV, Popovic J, Jacobson JD. The effect of letrozole on bone age progression, predicted adult height, and adrenal gland function. J Pediatr Endocrinol Metab. 2005 Mar; 18(3):285-93. PMID: 15813607.
-
Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics. 2003 Jan; 111(1):47-51. PMID: 12509553.
-
Schwartz ID, Grunt JA, Berg S, Jacobson JD, Moore WV, Howard CP. Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunction. J Pediatr Endocrinol Metab. 2000 Jun; 13(6):645-50. PMID: 10905389.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2000 | 1 | | 2003 | 1 | | 2005 | 2 | | 2008 | 3 | | 2011 | 1 | | 2013 | 3 | | 2015 | 4 | | 2016 | 1 | | 2017 | 1 | | 2019 | 1 | | 2020 | 1 | | 2023 | 2 |
To return to the timeline, click here.
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|